Evidence map›Paper›PMID 36509837›Full record

ReviewEuropean journal of human genetics : EJHG2023

Pathogenic REST variant causing Jones syndrome and a review of the literature.

Elisa Rahikkala, Johanna Julku, Sari Koskinen, Tommi Keski-Filppula, Stephanie Weissgraeber, Aida M Bertoli-Avella, Sanna Häkli, Minna Kraatari-Tiri

Open access · hybridAbstract readReview
In one paragraph

Review in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. 2023 in the European Journal of Human Genetics.European journal of human genetics : EJHG · 2024
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Elisa RahikkalaPEDEGO Research Unit, University of Oulu, Oulu, Finland. elisa.rahikkala@ppshp.fi.ORCID 0000-0003-2760-7059
Johanna JulkuDepartment of Oral and Maxillofacial Diseases, Oulu University Hospital, Oulu, Finland.ORCID 0000-0003-4777-3943
Sari KoskinenDepartment of Oral and Maxillofacial Diseases, Oulu University Hospital, Oulu, Finland.
Tommi Keski-FilppulaPEDEGO Research Unit, University of Oulu, Oulu, Finland.
Stephanie WeissgraeberDepartment of Medical Reporting and Genomics, Centogene GmbH, Rostock, Germany.ORCID 0000-0001-5013-4806
Aida M Bertoli-AvellaDepartment of Medical Reporting and Genomics, Centogene GmbH, Rostock, Germany.ORCID 0000-0001-9544-1877
Sanna HäkliPEDEGO Research Unit, University of Oulu, Oulu, Finland.
Minna Kraatari-TiriPEDEGO Research Unit, University of Oulu, Oulu, Finland.ORCID 0000-0002-8072-699X
Oulu University Hospital · FICentogene (Germany) · DE

Funding

Academy of Finland (Suomen Akatemia) 338446
6 · The paper itself

Abstract

Jones syndrome is a rare dominantly inherited syndrome characterized by gingival fibromatosis and progressive sensorineural hearing loss becoming symptomatic in the second decade of life. Here, we report a father and his two daughters presenting with a typical Jones syndrome (OMIM %135550) phenotype. Exome sequencing identified a repressor element 1-silencing transcription factor (REST, OMIM *600571) (NM_005612.5) c.2670_2673del p.(Glu891Profs*6) heterozygous variant segregating with Jones syndrome in the family. We review the clinical data from all previously published patients with Jones syndrome and previously published patients with pathogenic REST variants associated with gingival fibromatosis or sensorineural hearing loss. This study suggests that pathogenic REST variants cause Jones syndrome.

Indexed as

DeafnessFibromatosis, GingivalHearing Loss, SensorineuralHumansPedigree

Identifiers

PMID36509837
PMCPMC10133349
OpenAlexW4311826100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.